Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.4% | +24.7% | 1 / 3 | -6.3% | -0.48 pp | +1.04 pp | +28.7% | 2.35 | 2.99 | 486 | −6,3% | 32,3 | +11,1% | 2.99 | 6.11 | −51,0% |
| Pts | 0 | 0 | 4 | 0 | 4 | 8 | 12 | -4 | 12 | |||||||
Valuation annotation:Price: 15.200 (close price on 2026-10-19)EPS (TTM): 5.078
Financial charts
1.Revenue & growth
VND bn486Q2/26
1.Revenue & growth
VND bn486Q2/26
2.Profit & growth
VND bn30,4Q2/26
3.Profit mix (Penman)
VND bn150Q2/26
4.Margins & cost structure
%23.9%Q2/26
5.Returns & cash cycle
% · days17.2%Q2/26
6.Earnings quality & cash
VND bn292Q2/26
7.Asset structure
VND bn1.544Q2/26
8.Funding & debt health
VND bn · times1.544Q2/26
9.Revenue backlog
VND bn1,53Q2/26
10.Valuation
times · %3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.055Q2/26
Adjusted EPS growth, latest quarter
-1.4%
Average adjusted EPS growth, 3 quarters
24.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
17.1%
Source: vnstockData through Q2/26